insights_auto
Nega MBIO oshdi 3,07%?
Batafsil oʻrganishchevron_right
MBIO:NASDAQ
Mustang Bio Inc
0,41 US$
arrow_upward
+3,07%(+0,012) 1K
12-okt, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoMBIO tikeri uchun statistika yaratilmoqda...
Ochish
0,41 US$
Yuqori
0,44 US$
Past
0,38 US$
Bozor kapitali
3,13 mln
Oʻrtacha hajm
31,29 ming
Hajmi
54,38 ming
52 haftalik eng yuqori
1,69 US$
52 haftalik eng past
0,38 US$
Aksiya boʻyicha daromad
-0,46 US$
Beta
2,09
Muomaladagi aksiyalar
6,73 mln
Xodimlar soni
4
Ochish
0,41 US$
Yuqori
0,44 US$
Past
0,38 US$
Bozor kapitali
3,13 mln
Oʻrtacha hajm
31,29 ming
Hajmi
54,38 ming
52 haftalik eng yuqori
1,69 US$
52 haftalik eng past
0,38 US$
Aksiya boʻyicha daromad
-0,46 US$
Beta
2,09
Muomaladagi aksiyalar
6,73 mln
Xodimlar soni
4
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
https://www.dars.gov.et/
·
1 hafta oldin
MBIO Q4 2024 Earnings: Wider-Than-Expected Loss Per Share Dominates the Quarter - Profit Margin Analysis
Profil
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
Mustang Bio Inc haqida
CEOManuel Litchman
Xodimlar soni4
Asos solingan2015
Bosh ofislarWaltham, Massachusetts, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytmustangbio.com